Literature DB >> 34208050

Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins.

Eriko Ohgitani1, Masaharu Shin-Ya1, Masaki Ichitani2, Makoto Kobayashi2, Takanobu Takihara2, Masaya Kawamoto1, Hitoshi Kinugasa2, Osam Mazda1.   

Abstract

Potential effects of tea and its constituents on SARS-CoV-2 infection were assessed in vitro. Infectivity of SARS-CoV-2 was decreased to 1/100 to undetectable levels after a treatment with black tea, green tea, roasted green tea, or oolong tea for 1 min. An addition of (-) epigallocatechin gallate (EGCG) significantly inactivated SARS-CoV-2, while the same concentration of theasinensin A (TSA) and galloylated theaflavins including theaflavin 3,3'-di-O-gallate (TFDG) had more remarkable anti-viral activities. EGCG, TSA, and TFDG at 1 mM, 40 µM, and 60 µM, respectively, which are comparable to the concentrations of these compounds in tea beverages, significantly reduced infectivity of the virus, viral RNA replication in cells, and secondary virus production from the cells. EGCG, TSA, and TFDG significantly inhibited interaction between recombinant ACE2 and RBD of S protein. These results suggest potential usefulness of tea in prevention of person-to-person transmission of the novel coronavirus.

Entities:  

Keywords:  COVID-19; catechin; novel coronavirus; polyphenol; tea; theaflavin

Year:  2021        PMID: 34208050     DOI: 10.3390/molecules26123572

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  14 in total

1.  Are Antiviral Flavonoids Part of the Solution to the COVID-19 Pandemic?

Authors:  Joseph Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2021-12

2.  Investigation of the Azorean Camellia sinensis Processing Conditions to Maximize the Theaflavin 3,3'-di-O-Gallate Content as a Potential Antiviral Compound.

Authors:  Lisete Paiva; Elisabete Lima; Madalena Motta; Massimo Marcone; José Baptista
Journal:  Antioxidants (Basel)       Date:  2022-05-27

Review 3.  Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2.

Authors:  Abhishek Gour; Diksha Manhas; Swarnendu Bag; Bapi Gorain; Utpal Nandi
Journal:  Phytother Res       Date:  2021-03-30       Impact factor: 6.388

Review 4.  A Comprehensive Review of the Potential Use of Green Tea Polyphenols in the Management of COVID-19.

Authors:  Trina Ekawati Tallei; Nurdjannah Jane Niode; Rinaldi Idroes; B M Redwan Matin Zidan; Saikat Mitra; Ismail Celik; Firzan Nainu; Duygu Ağagündüz; Talha Bin Emran; Raffaele Capasso
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-03       Impact factor: 2.629

5.  Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor.

Authors:  Jinbiao Liu; Brittany H Bodnar; Fengzhen Meng; Adil I Khan; Xu Wang; Sami Saribas; Tao Wang; Saroj Chandra Lohani; Peng Wang; Zhengyu Wei; Jinjun Luo; Lina Zhou; Jianguo Wu; Guangxiang Luo; Qingsheng Li; Wenhui Hu; Wenzhe Ho
Journal:  Cell Biosci       Date:  2021-08-30       Impact factor: 7.133

6.  In vitro virucidal activity of the theaflavin-concentrated tea extract TY-1 against influenza A virus.

Authors:  Israa M A Mohamed; Haruko Ogawa; Yohei Takeda
Journal:  J Nat Med       Date:  2021-09-22       Impact factor: 2.343

7.  In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors.

Authors:  Rahul Singh; Vijay Kumar Bhardwaj; Jatin Sharma; Rituraj Purohit; Sanjay Kumar
Journal:  J Tradit Complement Med       Date:  2021-06-03

8.  Rapid Inactivation In Vitro of SARS-CoV-2 in Saliva by Black Tea and Green Tea.

Authors:  Eriko Ohgitani; Masaharu Shin-Ya; Masaki Ichitani; Makoto Kobayashi; Takanobu Takihara; Masaya Kawamoto; Hitoshi Kinugasa; Osam Mazda
Journal:  Pathogens       Date:  2021-06-08

9.  Anti-Influenza with Green Tea Catechins: A Systematic Review and Meta-Analysis.

Authors:  Anchalee Rawangkan; Kirati Kengkla; Sukrit Kanchanasurakit; Acharaporn Duangjai; Surasak Saokaew
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

10.  Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.

Authors:  Ming-Shao Tsai; Wei-Tai Shih; Yao-Hsu Yang; Yu-Shih Lin; Geng-He Chang; Cheng-Ming Hsu; Reming-Albert Yeh; Li-Hsin Shu; Yu-Ching Cheng; Hung-Te Liu; Yu-Huei Wu; Yu-Heng Wu; Rou-Chen Shen; Ching-Yuan Wu
Journal:  Biomed Pharmacother       Date:  2022-03-09       Impact factor: 7.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.